nimotuzumab

	nimotuzumab
Trade Name
Orphan Indication	Pancreatic cancer
USA Market Approval	USA
USA Designation Date	2015-09-08 00:00:00
Sponsor	InnoCIMab Pte Ltd;21 Bukit Batok Crescent, WCEGA Tower #14-78;